The Biggest Psychedelic News Stories of the Week – April 14
A wave of psychedelic news has hit the headlines as we see multiple states pushing for the decriminalization and advancement of psychedelics.
A wave of psychedelic news has hit the headlines as we see multiple states pushing for the decriminalization and advancement of psychedelics.
Health Canada’s decision to deny a terminally ill Saskatoon man permission to continue psychedelic psilocybin therapy has drawn a lot of attention and criticism from psychedelic advocates.
This week witnessed a wave of US states dwelling on psychedelic policies to be included in voting agendas, while cutting-edge DMT research is being subsidized for mental health studies.
This week, the psychedelic news-sphere has been abuzz with a few standout stories. From important policy updates to psychedelic IPOs, it’s clear that the field of psychedelics continues to grow and evolve at an exciting rate—so we’ve rounded up the top seven headlines here for your convenience.
The Aloha State’s Senate Committee recently approved a bill to form a “therapeutic psilocybin working group”, an endeavor that is sure to revolutionize medicinal practices and bring about ground-breaking breakthroughs in healthcare.
Advocate and activist Ashley Lukens has her reasons for supporting psychedelic medicine. They helped her battle cancer. Now she’s returning the favor.
Hawaii’s Senate unanimously voted to establish a working group to ensure the safety, accessibility, and affordability of psilocybin.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.